University of Münster
CRIS@UM
DE | EN

Stephan Borghorst

No current affiliations available for this person. The person is no longer active at the university.

Publications

Comparative pharmacokinetic/pharmacodynamic characterisation of a new pegylated recombinant E. coli L-asparaginase preparation (MC0609) in Beagle dog
Borghorst S, Hempel G, Poppenborg S, Franke D, König T, Baumgart J (2014)
In: Cancer Chemotherapy and Pharmacology, 74, 367-378.
Research article (journal) | Peer reviewed | Published
Population pharmacokinetics of native Escheria coli asparaginase
Borghorst S, Pieters R, Kuehnel HJ, Boos J, Hempel G (2012)
In: Clinical Trials, 29(2), 154-165. doi:10.3109/08880018.2011.627978
Research article (journal) | Peer reviewed | Published
Tigecycline (Tygacil®) for pediatric use: Overview of available data Tigecyclin (Tygacil®) in der pädiatrischen Anwendung: Überblick über die verfügbaren Daten
Borghorst S, Boos J (2011)
In: ((Bitte Journal prüfen)), 159(10), 955-959. doi:10.1007/s00112-011-2530-3
Research article (journal) | Peer reviewed | Published
Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007.
Schrey D, Borghorst S, Lanvers-Kaminsky C, Hempel G, Gerss J, Möricke A, Schrappe M, Boos J (2010)
In: Pediatric Blood and Cancer, 54(7), 952-958. doi:10.1002/pbc.22417
Research article (journal) | Peer reviewed | Published

Doctorates

Strategien zur Therapieoptimierung einer Asparaginasebehandlung unter Berücksichtigung populationspharmakokinetischer und immunologischer Aspekte
Candidate: Borghorst, Stephan | Supervisors: Hempel, Georg; Boos, Joachim
Period of time: until 12/06/2012
Doctoral examination procedure finished at: Doctoral examination procedure at University of Münster